The histone methyltransferase inhibitor BIX01294 enhances the cardiac potential of bone marrow cells

Stem Cells and Development

Volumn 22, Issue 4, 2013, Pages 654-667

  Mezentseva, Nadejda V ^a   Yang, Jinpu ^a   Kaur, Keerat ^a   Iaffaldano, Grazia ^a   Rémond, Mathieu C ^a   Eisenberg, Carol A ^a   Eisenberg, Leonard M ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE METHYLTRANSFERASE; N (1 BENZYL 4 PIPERIDINYL) 2 (HEXAHYDRO 4 METHYL 1H 1,4 DIAZEPIN 1 YL) 6,7 DIMETHOXY 4 QUINAZOLINAMINE;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; EMBRYONIC STEM CELL; GATA4 GENE; GENE; GENE EXPRESSION; HAND1 GENE; HAND2 GENE; HEART MUSCLE CELL; MOUSE; MYOCARDIN GENE; NKX2.5 GENE; NONHUMAN; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; TBX5 GENE; TITIN GENE; UPREGULATION;

ANIMALS; ANTIGENS, DIFFERENTIATION; AZEPINES; BONE MARROW CELLS; GENE EXPRESSION REGULATION; HISTONE-LYSINE N-METHYLTRANSFERASE; MICE; MUSCLE PROTEINS; MYOCARDIUM; MYOCYTES, CARDIAC; QUINAZOLINES;

EID: 84873355153     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2012.0181     Document Type: Article

References (94)

1. Takahashi K, K Tanabe, M Ohnuki, M Narita, T Ichisaka, K Tomoda and S Yamanaka. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872 (Pubitemid 350138099)
2. Amabile G and A Meissner. (2009). Induced pluripotent stem cells: current progress and potential for regenerative medicine. Trends Mol Med 15:59-68
3. Zhang J, GF Wilson, AG Soerens, CH Koonce, J Yu, SP Palecek, JA Thomson and TJ Kamp. (2009). Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 104:e30-e41
4. Nelson TJ, A Martinez-Fernandez and A Terzic. (2010). Induced pluripotent stem cells: developmental biology to regenerative medicine. Nat Rev Cardiol 7:700-710
5. Okita K, H Hong, K Takahashi and S Yamanaka. (2010). Generation of mouse-induced pluripotent stem cells with plasmid vectors. Nat Protoc 5:418-428
6. Hanna JH, K Saha and R Jaenisch. (2010). Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell 143:508-525
7. Zaehres H, JB Kim and HR Scholer. (2010). Induced pluripotent stem cells. Methods Enzymol 476:309-325
8. Duinsbergen D, D Salvatori, M Eriksson and H Mikkers. (2009). Tumors originating from induced pluripotent stem cells and methods for their prevention. Ann NY Acad Sci 1176:197-204
9. Fong CY, K Gauthaman and A Bongso. (2010). Teratomas from pluripotent stem cells: A clinical hurdle. J Cell Biochem 111:769-781
10. Wobus AM. (2010). The Janus face of pluripotent stem cells-connection between pluripotency and tumourigenicity. Bioessays 32:993-1002
11. Eisenberg LM and CA Eisenberg. (2004). Adult stem cells and their cardiac potential. Anat Rec 276A:103-112 (Pubitemid 38063879)
12. Hodgkinson T, XF Yuan and A Bayat. (2009). Adult stem cells in tissue engineering. Expert Rev Med Devices 6:621-640
13. Kuci S, Z Kuci, H Latifi-Pupovci, D Niethammer, R Handgretinger, M Schumm, G Bruchelt, P Bader and T Klingebiel. (2009). Adult stem cells as an alternative source of multipotential (pluripotential) cells in regenerative medicine. Curr Stem Cell Res Ther 4:107-117
14. Rooney GE, GI Nistor, FB Barry and HS Keirstead. (2010). In vitro differentiation potential of human embryonic versus adult stem cells. Regen Med 5:365-379
15. Eisenberg CA, JB Burch and LM Eisenberg. (2006). Bone marrow cells transdifferentiate to cardiomyocytes when introduced into the embryonic heart. Stem Cells 24:1236-1245 (Pubitemid 44464692)
16. Eisenberg LM, L Burns and CA Eisenberg. (2003). Hematopoietic cells from bone marrow have the potential to differentiate into cardiomyocytes in vitro. Anat Rec 274A: 870-882 (Pubitemid 37238386)
17. Rota M, J Kajstura, T Hosoda, C Bearzi, S Vitale, G Esposito, G Iaffaldano, ME Padin-Iruegas, A Gonzalez, et al. (2007). Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Natl Acad Sci U S A 104:17783-17788 (Pubitemid 350210912)
18. Martinez EC and T Kofidis. (2011). Adult stem cells for cardiac tissue engineering. J Mol Cell Cardiol 50:312-319
19. Streckfuss-Bomeke K, F Wolf, A Azizian, M Stauske, M Tiburcy, S Wagner, D Hubscher, R Dressel, S Chen, et al. (2012). Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts. Eur Heart J [Epub ahead of print]; DOI: 10.1093/eurheartj/ ehs203
20. Feng Y, Y Wang, N Cao and H Yang. (2012). Progenitor/ stem cell transplantation for repair of myocardial infarction: hype or hope? Ann Palliat Med 1:65-77
21. Jiang J, P Han, Q Zhang, J Zhao, Y Ma and M Mercola. (2012). Cardiac differentiation of human pluripotent stem cells. J Cell Mol Med 16:1663-1668
22. Ying QL, J Wray, J Nichols, L Batlle-Morera, B Doble, J Woodgett, P Cohen and A Smith. (2008). The ground state of embryonic stem cell self-renewal. Nature 453:519-523 (Pubitemid 351733324)
23. Silva J, O Barrandon, J Nichols, J Kawaguchi, TW Theunissen and A Smith. (2008). Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol 6:e253
24. Nusse R. (2008). Wnt signaling and stem cell control. Cell Res 18:523-527 (Pubitemid 351630946)
25. Ogawa K, R Nishinakamura, Y Iwamatsu, D Shimosato and H Niwa. (2006). Synergistic action of Wnt and LIF in maintaining pluripotency of mouse ES cells. Biochem Biophys Res Commun 343:159-166
26. Ichida JK, J Blanchard, K Lam, EY Son, JE Chung, D Egli, KM Loh, AC Carter, FP Di Giorgio, et al. (2009). A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell 5:491-503
27. Li W, W Wei, S Zhu, J Zhu, Y Shi, T Lin, E Hao, A Hayek, H Deng and S Ding. (2009). Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell 4:16-19
28. Mora-Castilla S, JR Tejedo, A Hmadcha, GM Cahuana, F Martin, B Soria and FJ Bedoya. (2010). Nitric oxide repression of Nanog promotes mouse embryonic stem cell differentiation. Cell Death Differ 17:1025-1033
29. Huangfu D, R Maehr, W Guo, A Eijkelenboom, M Snitow, AE Chen and DA Melton. (2008). Induction of pluripotent stem cells by defined factors is greatly improved by smallmolecule compounds. Nat Biotechnol 26:795-797 (Pubitemid 351961456)
30. Desponts C and S Ding. (2010). Using small molecules to improve generation of induced pluripotent stem cells from somatic cells. Methods Mol Biol 636:207-218
31. Feng B, JH Ng, JC Heng and HH Ng. (2009). Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell 4:301-312
32. Marson A, R Foreman, B Chevalier, S Bilodeau, M Kahn, RA Young and R Jaenisch. (2008). Wnt signaling promotes reprogramming of somatic cells to pluripotency. Cell Stem Cell 3:132-135
33. Martin BL and D Kimelman. (2010). Brachyury establishes the embryonic mesodermal progenitor niche. Genes Dev 24:2778-2783
34. Inman KE and KM Downs. (2006). Localization of Brachyury (T) in embryonic and extraembryonic tissues during mouse gastrulation. Gene Expr Patterns 6:783-793 (Pubitemid 44309433)
35. Kouskoff V, G Lacaud, S Schwantz, HJ Fehling and G Keller. (2005). Sequential development of hematopoietic and cardiac mesoderm during embryonic stem cell differentiation. Proc Natl Acad Sci U S A 102:13170-13175 (Pubitemid 41324997)
36. Saga Y, S Kitajima and S Miyagawa-Tomita. (2000). Mesp1 expression is the earliest sign of cardiovascular development. Trends Cardiovasc Med 10:345-352 (Pubitemid 32448044)
37. Wu SM. (2008). Mesp1 at the heart of mesoderm lineage specification. Cell Stem Cell 3:1-2
38. Bondue A and C Blanpain. (2010). Mesp1: a key regulator of cardiovascular lineage commitment. Circ Res 107:1414-1427
39. Nakano A, H Nakano and KR Chien. (2008). Multipotent islet-1 cardiovascular progenitors in development and disease. Cold Spring Harb Symp Quant Biol 73:297-306
40. Genead R, C Danielsson, AB Andersson, M Corbascio, A Franco-Cereceda, C Sylven and KH Grinnemo. (2010). Islet-1 cells are cardiac progenitors present during the entire lifespan: from the embryonic stage to adulthood. Stem Cells Dev 19:1601-1615
41. Brade T, S Gessert, M Kuhl and P Pandur. (2007). The amphibian second heart field: Xenopus islet-1 is required for cardiovascular development. Dev Biol 311:297-310 (Pubitemid 350046524)
42. Ma Q, B Zhou and WT Pu. (2008). Reassessment of Isl1 and Nkx2-5 cardiac fate maps using a Gata4-based reporter of Cre activity. Dev Biol 323:98-104
43. Allis CD, SL Berger, J Cote, S Dent, T Jenuwien, T Kouzarides, L Pillus, D Reinberg, Y Shi, et al. (2007). New nomenclature for chromatin-modifying enzymes. Cell 131: 633-636 (Pubitemid 350089969)
44. Feldman N, A Gerson, J Fang, E Li, Y Zhang, Y Shinkai, H Cedar and Y Bergman. (2006). G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat Cell Biol 8:188-194
45. Tachibana M, J Ueda, M Fukuda, N Takeda, T Ohta, H Iwanari, T Sakihama, T Kodama, T Hamakubo and Y Shinkai. (2005). Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9. Genes Dev 19:815-826
46. Golob JL, SL Paige, V Muskheli, L Pabon and CE Murry. (2008). Chromatin remodeling during mouse and human embryonic stem cell differentiation. Dev Dyn 237:1389-1398 (Pubitemid 351668820)
47. Bonasio R, S Tu and D Reinberg. (2010). Molecular signals of epigenetic states. Science 330:612-616
48. Shi Y, JT Do, C Desponts, HS Hahm, HR Scholer and S Ding. (2008). A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2:525-528 (Pubitemid 351729222)
49. Gellibert F, J Woolven, MH Fouchet, N Mathews, H Goodland, V Lovegrove, A Laroze, VL Nguyen, S Sautet, et al. (2004). Identification of 1,5-naphthyridine derivatives as a novel series of potent and selective TGF-beta type I receptor inhibitors. J Med Chem 47:4494-4506 (Pubitemid 39096837)
50. Eisenberg CA and LM Eisenberg. (1999). WNT11 promotes cardiac tissue formation of early mesoderm. Dev Dyn 216: 45-58 (Pubitemid 29416172)
51. Wobus AM, K Guan and U Pich. (2001). In vitro differentiation of embryonic stem cells and analysis of cellular phenotypes. Methods Mol Biol 158:263-286
52. Eisenberg CA and DM Bader. (1996). Establishment of the mesodermal cell line QCE-6. A model system for cardiac cell differentiation. Circ Res 78:205-216
53. Eisenberg LM and CA Eisenberg. (2007). Evaluating the role of Wnt signal transduction in promoting the development of the heart. ScientificWorldJournal 7:161-176 (Pubitemid 46219350)
54. Sineva GS and VA Pospelov. (2010). Inhibition of GSK3beta enhances both adhesive and signalling activities of betacatenin in mouse embryonic stem cells. Biol Cell 102:549-560
55. Chang AC, Y Fu, VC Garside, K Niessen, L Chang, M Fuller, A Setiadi, J Smrz, A Kyle, et al. (2011). Notch initiates the endothelial-to-mesenchymal transition in the atrioventricular canal through autocrine activation of soluble guanylyl cyclase. Dev Cell 21:288-300
56. Walther C and P Gruss. (1991). Pax-6, a murine paired box gene, is expressed in the developing CNS. Development 113:1435-1449
57. Bach A, Y Lallemand, MA Nicola, C Ramos, L Mathis, M Maufras and B Robert. (2003). Msx1 is required for dorsal diencephalon patterning. Development 130:4025-4036 (Pubitemid 37063421)
58. Khadka D, T Luo and TD Sargent. (2006). Msx1 and Msx2 have shared essential functions in neural crest but may be dispensable in epidermis and axis formation in Xenopus. Int J Dev Biol 50:499-502
59. Osumi N, H Shinohara, K Numayama-Tsuruta and M Maekawa. (2008). Concise review: Pax6 transcription factor contributes to both embryonic and adult neurogenesis as a multifunctional regulator. Stem Cells 26:1663-1672
60. Dziadek M and E Adamson. (1978). Localization and synthesis of alphafoetoprotein in post-implantation mouse embryos. J Embryol Exp Morphol 43:289-313 (Pubitemid 8280365)
61. Burtscher I and H Lickert. (2009). Foxa2 regulates polarity and epithelialization in the endoderm germ layer of the mouse embryo. Development 136:1029-1038
62. Taube JH, K Allton, SA Duncan, L Shen and MC Barton. (2010). Foxa1 functions as a pioneer transcription factor at transposable elements to activate Afp during differentiation of embryonic stem cells. J Biol Chem 285:16135-16144
63. Flaherty MP, A Abdel-Latif, Q Li, G Hunt, S Ranjan, Q Ou, XL Tang, RK Johnson, R Bolli and B Dawn. (2008). Noncanonical Wnt11 signaling is sufficient to induce cardiomyogenic differentiation in unfractionated bone marrow mononuclear cells. Circulation 117:2241-2252
64. Nagy, II, A Railo, R Rapila, T Hast, R Sormunen, P Tavi, J Rasanen and SJ Vainio. (2010). Wnt-11 signalling controls ventricular myocardium development by patterning Ncadherin and beta-catenin expression. Cardiovasc Res 85: 100-109
65. Eisenberg LM and CA Eisenberg. (2006). Wnt signal transduction and the formation of the myocardium. Dev Biol 293:305-315
66. Lako M, T Strachan, P Bullen, DI Wilson, SC Robson and S Lindsay. (1998). Isolation, characterisation and embryonic expression of WNT11, a gene which maps to 11q13.5 and has possible roles in the development of skeleton, kidney and lung. Gene 219:101-110 (Pubitemid 28470241)
67. Costa RH, VV Kalinichenko and L Lim. (2001). Transcription factors in mouse lung development and function. Am J Physiol Lung Cell Mol Physiol 280:L823-L838
68. Weng T and L Liu. (2010). The role of pleiotrophin and betacatenin in fetal lung development. Respir Res 11:80
69. Lou Y, A Javed, S Hussain, J Colby, D Frederick, J Pratap, R Xie, T Gaur, AJ van Wijnen, et al. (2009). A Runx2 threshold for the cleidocranial dysplasia phenotype. Hum Mol Genet 18:556-568
70. Napierala D, K Sam, R Morello, Q Zheng, E Munivez, RA Shivdasani and B Lee. (2008). Uncoupling of chondrocyte differentiation and perichondrial mineralization underlies the skeletal dysplasia in tricho-rhino-phalangeal syndrome. Hum Mol Genet 17:2244-2254 (Pubitemid 351911990)
71. Mansouri A, G Goudreau and P Gruss. (1999). Pax genes and their role in organogenesis. Cancer Res 59:1707s-1709s; discussion 1709s-1710s
72. Villanueva S, C Cespedes, A Gonzalez and CP Vio. (2006). bFGF induces an earlier expression of nephrogenic proteins after ischemic acute renal failure. Am J Physiol Regul Integr Comp Physiol 291:R1677-R1687 (Pubitemid 44904135)
73. Falahatpisheh MH, A Nanez and KS Ramos. (2011). AHR regulates WT1 genetic programming during murine nephrogenesis. Mol Med 17:1275-1284
74. Zhou B, Q Ma, S Rajagopal, SM Wu, I Domian, J Rivera- Feliciano, D Jiang, A von Gise, S Ikeda, KR Chien and WT Pu. (2008). Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature 454:109-113 (Pubitemid 351931979)
75. Eisenberg LM and CA Eisenberg. (2002). Onset of a cardiac phenotype in the early embryo. In: Cardiovascular Molecular Morphogenesis: Myofibrillogenesis. Dube DK, ed. Springer Verlag, New York, NY, pp 181-205
76. Eisenberg LM, R Moreno and RR Markwald. (2005). Multiple stem cell populations contribute to the formation of the myocardium. Ann NY Acad Sci 1047:38-49 (Pubitemid 41123826)
77. Segers VF and RT Lee. (2008). Stem-cell therapy for cardiac disease. Nature 451:937-942 (Pubitemid 351301749)
78. Freund C and CL Mummery. (2009). Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models. J Cell Biochem 107:592-599
79. Linke A, P Muller, D Nurzynska, C Casarsa, D Torella, A Nascimbene, C Castaldo, S Cascapera, M Bohm, et al. (2005). Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci U S A 102: 8966-8971 (Pubitemid 40881062)
80. Rota M, ME Padin-Iruegas, Y Misao, A De Angelis, S Maestroni, J Ferreira-Martins, E Fiumana, R Rastaldo, ML Arcarese, et al. (2008). Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res 103:107-116
81. van Laake LW, R Passier, PA Doevendans and CL Mummery. (2008). Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents. Circ Res 102: 1008-1010 (Pubitemid 351667854)
82. Fuh E and TJ Brinton. (2009). Bone marrow stem cells for the treatment of ischemic heart disease: a clinical trial review. J Cardiovasc Transl Res 2:202-218
83. Kearns-Jonker M, W Dai and RA Kloner. (2010). Stem cells for the treatment of heart failure. Curr Opin Mol Ther 12:432-441
84. Sanz-Ruiz R, E Gutierrez Ibanes, AV Arranz, ME Fernandez Santos, PL Fernandez and F Fernandez-Aviles. (2010). Phases I-III clinical trials using adult stem cells. Stem Cells Int 2010:579142
85. Ballard VL. (2010). Stem cells for heart failure in the aging heart. Heart Fail Rev 15:447-456
86. Mummery CL, RP Davis and JE Krieger. (2010). Challenges in using stem cells for cardiac repair. Sci Transl Med 2: 27ps17
87. Kajstura J, N Gurusamy, B Ogorek, P Goichberg, C Clavo- Rondon, T Hosoda, D D'Amario, S Bardelli, AP Beltrami, et al. (2010). Myocyte turnover in the aging human heart. Circ Res 107:1374-1386
88. Kajstura J, K Urbanek, S Perl, T Hosoda, H Zheng, B Ogorek, J Ferreira-Martins, P Goichberg, C Rondon-Clavo, et al. (2010). Cardiomyogenesis in the adult human heart. Circ Res 107:305-315
89. Davis DR, E Kizana, J Terrovitis, AS Barth, Y Zhang, RR Smith, J Miake and E Marban. (2010). Isolation and expansion of functionally-competent cardiac progenitor cells directly from heart biopsies. J Mol Cell Cardiol 49:312-321
90. Willems E, S Spiering, H Davidovics, M Lanier, Z Xia, M Dawson, J Cashman and M Mercola. (2011). Small-molecule inhibitors of the Wnt pathway potently promote cardiomyocytes from human embryonic stem cell-derived mesoderm. Circ Res 109:360-364
91. Yang L, MH Soonpaa, ED Adler, TK Roepke, SJ Kattman, M Kennedy, E Henckaerts, K Bonham, GW Abbott, et al. (2008). Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 453:524-528 (Pubitemid 351733312)
92. Makino S, K Fukuda, S Miyoshi, F Konishi, H Kodama, J Pan, M Sano, T Takahashi, S Hori, et al. (1999). Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103:697-705 (Pubitemid 29122423)
93. Rajasingh J, J Thangavel, MR Siddiqui, I Gomes, XP Gao, R Kishore and AB Malik. (2011). Improvement of cardiac function in mouse myocardial infarction after transplantation of epigenetically-modified bone marrow progenitor cells. PLoS One 6:e22550
94. Ieda M, JD Fu, P Delgado-Olguin, V Vedantham, Y Hayashi, BG Bruneau and D Srivastava. (2010). Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142:375-386.